Back to Search Start Over

[SARS-CoV-2 infection (COVID-19): what can we expect?]

Authors :
Kern WV
Biever PM
Rieg S
Panning M
Source :
Deutsche medizinische Wochenschrift (1946) [Dtsch Med Wochenschr] 2020 Jun; Vol. 145 (11), pp. 740-746. Date of Electronic Publication: 2020 Jun 03.
Publication Year :
2020

Abstract

- Case numbers in China are clearly declining, case numbers in many European regions are no longer increasing exponentially.- Data on mortality from SARS-CoV-2 infection are contradictory; mortality is certainly lower than for SARS and MERS, but probably higher than for most seasonal flu outbreaks in recent years- The main complication of SARS-CoV-2 infection is pneumonia with development of acute respiratory distress syndrome (ARDS)- Asymptomatic and oligosymptomatic courses with virus shedding are not uncommon; they may be more frequent in children than in adults. Virus excretion in asymptomatic people and in the pre-symptomatic phase of an infection is relevant for transmission- An effective antiviral therapy has not yet been established. Steroids for anti-inflammatory therapy are not recommended- It is very important to prepare all actors in the health care system for a longer-term burden of inpatients and complications and to create the necessary capacities. Low-threshold diagnostic testing and rapid detection of infection chains remain essential for better control of the pandemic. An effective vaccine is urgent.<br />Competing Interests: Die Autorinnen/Autoren geben an, dass kein Interessenkonflikt besteht.<br /> (© Georg Thieme Verlag KG Stuttgart · New York.)

Details

Language :
German
ISSN :
1439-4413
Volume :
145
Issue :
11
Database :
MEDLINE
Journal :
Deutsche medizinische Wochenschrift (1946)
Publication Type :
Academic Journal
Accession number :
32492743
Full Text :
https://doi.org/10.1055/a-1114-3699